Pictet Asset Management (UK)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$1.53B Buy
3,037,588
+263,116
+9% +$124M 1.67% 1
2021
Q1
$1.27B Buy
2,774,472
+93,135
+3% +$44.5M 1.52% 1
2020
Q4
$1.25B Sell
2,681,337
-122,947
-4% -$57.6M 1.63% 2
2020
Q3
$1.24B Sell
2,804,284
-41,544
-1% -$17.2M 1.94% 2
2020
Q2
$1.03B Buy
2,845,828
+71,739
+3% +$24M 1.78% 3
2020
Q1
$787M Buy
2,774,089
+137,370
+5% +$43.3M 1.68% 2
2019
Q4
$857M Sell
2,636,719
-88,412
-3% -$26.8M 1.51% 1
2019
Q3
$794M Sell
2,725,131
-69,232
-2% -$19.8M 1.67% 1
2019
Q2
$821M Sell
2,794,363
-38,067
-1% -$10.5M 1.77% 1
2019
Q1
$775M Sell
2,832,430
-75,475
-3% -$18.8M 1.71% 1
2018
Q4
$651K Sell
2,907,905
-122,941
-4% -$28.8M 1.63% 2
2018
Q3
$740M Sell
3,030,846
-2,822
-0.1% -$649K 1.56% 3
2018
Q2
$628M Buy
3,033,668
+142,311
+5% +$30.2M 1.5% 2
2018
Q1
$597M Buy
2,891,357
+122,108
+4% +$25.6M 1.47% 2
2017
Q4
$526M Buy
2,769,249
+354,889
+15% +$68M 1.35% 2
2017
Q3
$457M Sell
2,414,360
-1,492
-0.1% -$270K 1.29% 2
2017
Q2
$417M Buy
2,415,852
+8,388
+0.3% +$1.41M 1.28% 2
2017
Q1
$370M Buy
2,407,464
+29,513
+1% +$4.51M 1.21% 2
2016
Q4
$336M Buy
2,377,951
+484,035
+26% +$71.4M 1.25% 3
2016
Q3
$301M Sell
1,893,916
-25,403
-1% -$3.91M 1.13% 4
2016
Q2
$291M Buy
1,919,319
+214,750
+13% +$31.7M 1.14% 4
2016
Q1
$220M Sell
1,704,569
-242,007
-12% -$32.4M 0.97% 10
2015
Q4
$276M Buy
1,946,576
+148,110
+8% +$19.8M 1.17% 6
2015
Q3
$220M Sell
1,798,466
-18,792
-1% -$2.45M 0.97% 14
2015
Q2
$254M Buy
1,817,258
+211,150
+13% +$27.5M 1.04% 10
2015
Q1
$202M Buy
1,606,108
+276,092
+21% +$35.6M 0.84% 16
2014
Q4
$167M Buy
1,330,016
+102,262
+8% +$12.4M 0.75% 19
2014
Q3
$149M Sell
1,227,754
-1,713
-0.1% -$208K 0.72% 24
2014
Q2
$145M Sell
1,229,467
-82,006
-6% -$9.65M 0.69% 25
2014
Q1
$158M Buy
1,311,473
+365,739
+39% +$43.5M 0.79% 18
2013
Q4
$105M Buy
945,734
+499,834
+112% +$49.7M 0.54% 43
2013
Q3
$41.1M Buy
445,900
+25,300
+6% +$2.29M 0.23% 120
2013
Q2
$35.6M Buy
+420,600
New +$35M 0.2% 122

Other funds holding TMO

Pictet Asset Management (UK)'s TMO Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Thermo Fisher Scientific (TMO) stake by 9.5% in Q2 2021, buying an estimated $124M and bringing the position to 3,037,588 shares worth $1.53B. The position accounts for 1.67% of the portfolio, ranked #1.

Pictet Asset Management (UK) first reported a position in TMO in Q2 2013 and has held it in 33 quarters since. 2,074 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

  • Pictet Asset Management (UK) held 3,037,588 shares of Thermo Fisher Scientific worth $1.53B as of Q2 2021.
  • Pictet Asset Management (UK) bought 263,116 Thermo Fisher Scientific shares in Q2 2021, an estimated $124M.
  • Thermo Fisher Scientific made up 1.67% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1 holding.
  • Pictet Asset Management (UK) first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 33 quarters since.
  • 2,074 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.